Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis

Annals of the Rheumatic Diseases

Volumn 65, Issue 3, 2006, Pages 312-315

  Beeharry, D ^a   Coupe, B ^b   Benbow, E W ^a   Morgan, J ^a   Kwok, S ^a   Charlton Menys, V ^a   France, M ^a   Durrington, P N ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ACHILLES TENDON; ADULT; ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOOT PAIN; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; TENOSYNOVITIS; XANTHOMA;

ACHILLES TENDON; ADULT; CHOLESTEROL; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; TENOSYNOVITIS;

EID: 33144474424     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.040766     Document Type: Article

References (24)

1. Goldstein JL, Brown MD, Familial hypercholesterolaemia, In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 8th ed. New York: McGraw-Hill, 2001:2863-913.
2. Marks D, Thorogood M, Neil HAW, Humphries SE. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 2003;168:1-14.
3. Neil HAW, Hawkins MM, Durrington PN, Betteridge DJ, Capps N, Humphries SE. Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective study. Atherosclerosis 2005;179:293-7.
4. Talmud P, Tybjaerg-Hansen A, Bhatnagar D, MBewu AD, Durrington PN, Miller JP, et al. Screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis 1991;89:137-42.
5. Myant NB, Slack J. Type II hyperlipoproteinaemia. Clin Endocrinol Metab 1973;2:81-109.
6. Thompson GR, Seed M, Niththyananthan S, McCarthy S, Thorogood M. Genotypic and phenotypic variations in familial hypercholesterolemia. Arteriosclerosis 1989;9(suppl):176-80.
7. Björkhem I, Boberg KM, Leitersdorf E. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:2961-88.
8. Bhatnagar D, Morgan J, Siddiq S, Mackness MI, Miller JP, Durrington PN. Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia. BMJ. 2000;321, 1497-500 with full version available at http://www.bmj.com.
9. Glueck CJ, Levy RI, Fredrickson DS. Acute tendonitis and arthritis. A presenting symptom of familial type 2 hyperlipoproteinemia. JAMA 1968;2006:2895-7.
10. Shapiro JR, Fallat RW, Tsang RC, Glueck CJ. Achilles tendonitis and tenosynovitis. A diagnostic manifestation of familial type 2 hyperlipoproteinemia in children. Am J Dis Child 1974;128:486-90.
11. Klemp P, Halland AM, Majoos FL, Steyn K. Musculoskeletal manifestations in hyperlipidaemia: a controlled study. Ann Rheum Dis 1993;52:44-8.
12. Betteridge DJ, Broome K, Durrington PN, Hawkins MM, Humphries SE, Mann JI, et al. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis 1999;142:105-12.
13. Bentley G, Shearer JR. The foot and ankle. In: Duthie RB, Bentley G, eds. Mercer's orthopaedic surgery. 9th ed. London: Arnold, 1996:1193-253.
14. Solomin L, Warwick DJ, Nayagam S. The ankle and foot. In: Apley's system of orthopaedics and fractures. 8th ed. London: Arnold, 2001:485-517.
15. Cooper PS. The foot and ankle. In: Wiesel SW, Delahay JN, eds. Principles of orthopaedic medicine and surgery. Philadelphia: Saunders, 2001:767-830.
16. Murphy GA. Disorders of tendons and fascia. In: Canale ST, eds. Campbell's operative orthopedics. 10th ed. St Louis: Mosby, 2003:4189-230.
17. Fagge CH. General xanthelesma or vitiligoidea. Trans Path Soc Lond 1873;24:242-50.
18. Jensen J. The story of xanthomatosis in England prior to the first world war. Clio Medica 1967;2:289-305.
19. Takahashi W, Naito M. Lipid storage disease. Part 1: Ultrastructure of xanthoma cells in various diseases. Acta Pathol Jpn 1983;33:959-77.
20. Durrington PN, Adams JE, Beastall MD. The assessment of Achilles tendon size in primary hypercholesterolaemia by computed tomography. Atherosclerosis 1982;45:345-58.
21. Dussault RG, Kaplan PA, Roederer G. MR imaging of Achilles tendon in patients with familial hyperlipidaemia: comparison with plain films, physical examination, and patients with traumatic tendon lesions. Am J Roentgenol 1995;164:403-7.
22. Kane JP, Malloy MJ, Tun P, Phillips NR, Freedman DD, Williams ML et al. Normalisations of LDL levels in heterozygous familial hypercholesterolemia with a combined drug regimen. N Engl J Med 1981;304:251-7.
23. Yamamoto A, Matsuzawa Y, Yokoyama S, Funahashi T, Yamamwa T, Kishino B-I. Effects of probucol on xanthoma regression in familial hypercholesterolemia. Am J Cardiol 1986;57:29-35H.
24. Spengel FA, Jadhav A, Duffield RGM, Wood CB, Thompson GR. Superiority or partial ileal bypass over cholestyramine in reducing cholesterol in familial hypercholesterolaemia. Lancet 1981;ii:768-71.